|

XYA02 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • XYone Therapeutics, Inc1

Indications

  • MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors1
  • GEJ Adenocarcinoma1
  • Pancreatic Adenocarcinoma1
  • Ovarian Cancer1
  • Colorectal Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.